Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00619281
Other study ID # CI-11-2007
Secondary ID klilu-11-2007-al
Status Completed
Phase N/A
First received December 28, 2007
Last updated November 23, 2009
Start date October 2007
Est. completion date July 2008

Study information

Verified date November 2009
Source Klinikum Ludwigshafen
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Observational

Clinical Trial Summary

Low output syndrome is a common complication in patients undergoing cardiac surgery. Its incidence was reported to be 2 to 6% [1]. Morbidity and mortality of low output syndrome is high and the costs for treating the disease are immense.

The primary objective of this prospective observational study is to define a threshold for a critically reduced cardiac output requiring immediate therapy.


Description:

Low output syndrome is a common complication in patients undergoing cardiac surgery. Its incidence was reported to be 2 to 6% [1]. In patients suffering from low output syndrome cardiac output is severely reduced due to myocardial failure. Among other reasons for myocardial failure, ischemia, insufficient myocardial protection during aortic cross-clamping, and severely reduced ventricular function prior surgery are the most common risk factors for low output syndrome. Low output syndrome is treated with positive inotropic drugs and mechanical assist devices [2]. Morbidity and mortality of low output syndrome is high and the costs for treating the disease are immense.

If cardiac output cannot be increased cardiac failure persist and vital organs are hypoperfused. Critical and prolonged hypoperfusion results in single and multi organ failure. Until today a definite threshold for a critically reduced cardiac output or cardiac index requiring immediate therapy is not completely known. Cardiogenic shock is diagnosed by clinical signs and it is not diagnosed by cardiac output or cardiac index. The critical value for a severely reduces cardiac index was reported to be in a range of 1.75 to 2.5L/min/m² [3-5].

The primary objective of this prospective observational study in 600 patients undergoing cardiac surgery is to try to define a threshold for a critically reduced cardiac output or cardiac index requiring immediate therapy.

If cardiac output and cardiac index are not reduced below a critical threshold, morbidity, mortality, and length of stay in the intensive care unit and in the hospital are reduced [6].


Recruitment information / eligibility

Status Completed
Enrollment 600
Est. completion date July 2008
Est. primary completion date July 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients undergoing cardiac surgery,

- Written informed consent

Exclusion Criteria:

- Missing consent

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Germany Klinikum der Stadt Ludwigshafen, Department of Anesthesiology and Intensive Care Medicine Ludwigshafen

Sponsors (3)

Lead Sponsor Collaborator
Klinikum Ludwigshafen Klinikum der Stadt Ludwigshafen, Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Department of Cardiac Surgery

Country where clinical trial is conducted

Germany, 

References & Publications (6)

Adams HA, Baumann G, Gänsslen A, Janssens U, Knoefel W, Koch T, Marx G, Müller-Werdan U, Pape HC, Prange W, Roesner D, Standl T, Teske W, Werner G, Zander R; I.A.G.-Schock. [Definition of shock types]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2001 Nov;36 Suppl 2:S140-3. German. — View Citation

Böhrer H, Schmidt H, Motsch J, Gust R, Bach A, Martin E. Gastric intramucosal pH: a predictor of survival in cardiac surgery patients with low cardiac output? J Cardiothorac Vasc Anesth. 1997 Apr;11(2):184-6. — View Citation

Hausmann H, Potapov EV, Koster A, Krabatsch T, Stein J, Yeter R, Kukucka M, Sodian R, Kuppe H, Hetzer R. Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score. Circulation. 2002 Sep 24;106(12 Suppl 1):I203-6. — View Citation

Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999 Aug 26;341(9):625-34. — View Citation

Lehmann A, Boldt J. New pharmacologic approaches for the perioperative treatment of ischemic cardiogenic shock. J Cardiothorac Vasc Anesth. 2005 Feb;19(1):97-108. Review. — View Citation

Pölönen P, Ruokonen E, Hippeläinen M, Pöyhönen M, Takala J. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg. 2000 May;90(5):1052-9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The primary objective is to try to define a threshold value for a critically reduced cardiac output or cardiac index requiring immediate therapy to reduce mortality and morbidity. 90 days Yes
See also
  Status Clinical Trial Phase
Unknown status NCT00549107 - Prophylactic Use of Levosimendan Versus Milrinone in Open Heart Surgery in Infants Phase 2
Completed NCT04045340 - Intraoperative Global Longitudinal Strain and Global Longitudinal Strain Rate as Predictors of Unfavorable Outcome in On-Pump Mitral Surgery
Completed NCT01576094 - Two Inodilators Postsurgery in Neonates Phase 1/Phase 2
Completed NCT00994825 - Levosimendan in High Risk Patients Undergoing Cardiac Surgery Phase 4
Completed NCT03143348 - Prognostic Markers of Inflammation in Infants Undergoing Cardiopulmonary Bypass
Completed NCT02025621 - Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass Phase 3
Completed NCT00695929 - Levosimendan in Congenital Cardiac Surgery N/A
Completed NCT03661385 - Nitric Oxide During Bypass for Arterial Switch Operation Phase 3
Completed NCT01120106 - Levosimendan Administration in Neonates With Transposition of the Great Arteries Phase 2
Recruiting NCT03823781 - Prophylactic Use of Milrinone After Congenital Heart Surgery in Infants Phase 3
Completed NCT01328912 - Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients Phase 3
Recruiting NCT03558269 - Autologous Umbilical Cord Blood Treatment of Neonate With CHD Phase 1/Phase 2
Recruiting NCT04405856 - Outcome of Patients Treated With IABP
Recruiting NCT04698005 - Exogenous Ketones for Acutely Decompensated HEart Failure Phase 3
Active, not recruiting NCT05514652 - Anesthesia Standard Operating Procedure During On-pump Coronary Artery Bypass Grafting N/A
Recruiting NCT06355882 - Patients With Low Cardiac Output Syndrome Undergoing Local Dental Anesthesia N/A
Completed NCT03207165 - Milrinone Versus Dobutamine in Critically Ill Patients Phase 4